Patents by Inventor Magali Saint-Geniez

Magali Saint-Geniez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Endomucin inhibitor as an anti-angiogenic agent
    Patent number: 11680266
    Abstract: A method for reducing neovascularization in an ocular tissue is carried out by contacting the tissue with an inhibitor of endomucin expression or activity.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: June 20, 2023
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Patricia A. D'Amore, Magali Saint-Geniez, Cindy Park-Windhol
  • ENDOMUCIN INHIBITOR AS AN ANTI-ANGIOGENIC AGENT
    Publication number: 20210163955
    Abstract: A method for reducing neovascularization in an ocular tissue is carried out by contacting the tissue with an inhibitor of endomucin expression or activity.
    Type: Application
    Filed: December 2, 2020
    Publication date: June 3, 2021
    Inventors: Patricia A. D'Amore, Magali Saint-Geniez, Cindy Park-Windhol
  • Endomucin inhibitor as an anti-angiogenic agent
    Patent number: 10883108
    Abstract: A method for reducing neovascularization in an ocular tissue is carried out by contacting the tissue with an inhibitor of endomucin expression or activity.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: January 5, 2021
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Patricia A. D'Amore, Magali Saint-Geniez, Cindy Park-Windhol
  • Endomucin Inhibitor as an Anti-Angiogenic Agent
    Publication number: 20190112610
    Abstract: A method for reducing neovascularization in an ocular tissue is carried out by contacting the tissue with an inhibitor of endomucin expression or activity.
    Type: Application
    Filed: March 31, 2017
    Publication date: April 18, 2019
    Applicant: The Schepens Eye Research Institute, Inc.
    Inventors: Patricia A. D'Amore, Magali Saint-Geniez, Cindy Park-Windhol
  • Predicting retinal degeneration based on three-dimensional modeling of oxygen concentration
    Patent number: 9986905
    Abstract: In some example implementations, there is provided a method for predicting retinal degeneration in multiple eye diseases. The method may include receiving three-dimensional data representative of a plurality of layers of a retina of a subject under test; determining, from the received data, oxygen concentration at one or more of the plurality of layers; detecting, based on the determined oxygen concentration, a region of at least one a high oxygen concentration in the retina or a low oxygen concentration in the retina; and comparing the detected region to reference data to determine whether the retina including the detected region suffers from or will suffer from at least one of a retinal disease or a degeneration of the retina. Related apparatus are also disclosed.
    Type: Grant
    Filed: April 23, 2014
    Date of Patent: June 5, 2018
    Assignee: The Schepens Eye Research Institute, Inc.
    Inventors: Kevin McHugh, Magali Saint-Geniez, Leo Kim
  • Predicting Retinal Degeneration Based On Three-Dimensional Modeling Of Oxygen Concentration
    Publication number: 20160100752
    Abstract: In some example implementations, there is provided a method for predicting retinal degeneration in multiple eye diseases. The method may include receiving three-dimensional data representative of a plurality of layers of a retina of a subject under test; determining, from the received data, oxygen concentration at one or more of the plurality of layers; detecting, based on the determined oxygen concentration, a region of at least one a high oxygen concentration in the retina or a low oxygen concentration in the retina; and comparing the detected region to reference data to determine whether the retina including the detected region suffers from or will suffer from at least one of a retinal disease or a degeneration of the retina. Related apparatus are also disclosed.
    Type: Application
    Filed: April 23, 2014
    Publication date: April 14, 2016
    Inventors: Kevin McHugh, Magali Saint-Geniez, Leo Kim
  • SCAFFOLD FOR SUBRETINAL CELL TRANSPLANTATION AND DRUG DELIVERY
    Publication number: 20140234381
    Abstract: The following disclosure provides compositions and methods for the repairing of a diseased or disordered retina, for example, in patients suffering from age-related macular degeneration (AMD).
    Type: Application
    Filed: December 23, 2013
    Publication date: August 21, 2014
    Applicants: The Charles Stark Draper Laboratory, Inc., The Schepens Eye Research Institute, Inc.
    Inventors: Sarah L. Tao, Stephen Redenti, Magali Saint-Geniez, Michael Young, Patricia D'Amore